The lawsuits come as Novo Nordisk grapples with shortages of Wegovy and Ozempic in the U.S. due to skyrocketing demand.
from Health and Science https://ift.tt/HX9DGTQ
https://ift.tt/Aac3zd5
https://ift.tt/937yHq0
Thursday, 30 November 2023
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of AbbVie's buyout of ImmunoGen.
from Health and Science https://ift.tt/vn93R4p
https://ift.tt/Aac3zd5
https://ift.tt/937yHq0
from Health and Science https://ift.tt/vn93R4p
https://ift.tt/Aac3zd5
https://ift.tt/937yHq0
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
The one thing that experts, along with vaccine makers, can agree on is that low vaccination rates put people at risk of getting severe Covid infections.
from Health and Science https://ift.tt/Zsc71xw
https://ift.tt/oiNWj70
https://ift.tt/b4RI3UE
from Health and Science https://ift.tt/Zsc71xw
https://ift.tt/oiNWj70
https://ift.tt/b4RI3UE
Wednesday, 29 November 2023
Cigna shares slide after report it could merge with Humana
Shares of Cigna slid after a report that the company is in talks with Humana about a merger between the two health care giants.
from Health and Science https://ift.tt/YOXDK8o
https://ift.tt/oiNWj70
https://ift.tt/b4RI3UE
from Health and Science https://ift.tt/YOXDK8o
https://ift.tt/oiNWj70
https://ift.tt/b4RI3UE
Monday, 27 November 2023
Jim Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
from Health and Science https://ift.tt/2Cc18Dp
https://ift.tt/5L2UPMC
https://ift.tt/4f6FyKX
from Health and Science https://ift.tt/2Cc18Dp
https://ift.tt/5L2UPMC
https://ift.tt/4f6FyKX
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Patients on Eli Lilly's Mounjaro were more likely to lose weight and experienced larger reductions in body weight compared to those on Novo Nordisk's Ozempic.
from Health and Science https://ift.tt/R5Lpvb0
https://ift.tt/5L2UPMC
https://ift.tt/4f6FyKX
from Health and Science https://ift.tt/R5Lpvb0
https://ift.tt/5L2UPMC
https://ift.tt/4f6FyKX
Sunday, 26 November 2023
Here's how the American Red Cross makes money from donated blood
In 2022, the American Red Cross made $1.8 billion selling blood to hospitals and medical facilities across the country.
from Health and Science https://ift.tt/dq6C1ih
https://ift.tt/4rpuqZW
https://ift.tt/H7JNagF
from Health and Science https://ift.tt/dq6C1ih
https://ift.tt/4rpuqZW
https://ift.tt/H7JNagF
Friday, 24 November 2023
China reports no 'unusual or novel pathogens' after WHO seeks data on respiratory illness outbreak
The WHO said that the surge was likely linked to the lifting of Covid-19 restrictions as China experiences its first full winter season since declaring an end to the pandemic in December.
from Health and Science https://ift.tt/FAjiLRh
https://ift.tt/BOoY9rb
https://ift.tt/1xcFvmQ
from Health and Science https://ift.tt/FAjiLRh
https://ift.tt/BOoY9rb
https://ift.tt/1xcFvmQ
Monday, 20 November 2023
U.S. to offer another round of free at-home Covid tests starting Monday
Starting Monday, Americans can request four additional free at-home Covid-19 test kits through the Biden administration's website.
from Health and Science https://ift.tt/KkyGVno
https://ift.tt/hip8BRL
https://ift.tt/a5QJftF
from Health and Science https://ift.tt/KkyGVno
https://ift.tt/hip8BRL
https://ift.tt/a5QJftF
'The silent pandemic': A hotter world makes it harder to stop the spread of deadly superbugs
Research has shown the climate crisis is exacerbating the AMR phenomenon in several ways.
from Health and Science https://ift.tt/MHlLW7k
https://ift.tt/hip8BRL
https://ift.tt/a5QJftF
from Health and Science https://ift.tt/MHlLW7k
https://ift.tt/hip8BRL
https://ift.tt/a5QJftF
Friday, 17 November 2023
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.
from Health and Science https://ift.tt/3mR0XzY
https://ift.tt/D6IVbW3
https://ift.tt/fld7uQK
from Health and Science https://ift.tt/3mR0XzY
https://ift.tt/D6IVbW3
https://ift.tt/fld7uQK
Monday, 13 November 2023
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Analysts said upcoming data on Pfizer's obesity pill, danuglipron, will be crucial to how competitive the company can be against Eli Lilly and Novo Nordisk.
from Health and Science https://ift.tt/VJaSF7x
https://ift.tt/9Fx6nyb
https://ift.tt/r1Bs8g2
from Health and Science https://ift.tt/VJaSF7x
https://ift.tt/9Fx6nyb
https://ift.tt/r1Bs8g2
Amputees say this bionic hand startup gives them both strength and grace — they can even pick up raw eggs without crushing them
Aether Biomedical's bionic hand can lift up to 77 pounds and switch between 12 different customizable grip patterns.
from Health and Science https://ift.tt/A0nuFLY
https://ift.tt/9Fx6nyb
https://ift.tt/r1Bs8g2
from Health and Science https://ift.tt/A0nuFLY
https://ift.tt/9Fx6nyb
https://ift.tt/r1Bs8g2
Saturday, 11 November 2023
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
The findings could expand use of Wegovy and help Novo maintain its lead over Eli Lilly, whose competing weight-loss drug Zepbound was just approved in the U.S.
from Health and Science https://ift.tt/GM3mCFZ
https://ift.tt/PVX09YR
https://ift.tt/qQxePGK
from Health and Science https://ift.tt/GM3mCFZ
https://ift.tt/PVX09YR
https://ift.tt/qQxePGK
Friday, 10 November 2023
Patients are lining up for $2,500 full-body MRI scans that can detect cancer early
Thousands of people have paid $2,500 for full-body MRI scans from Prenuvo, whose technology can detect more than 500 health conditions
from Health and Science https://ift.tt/DCA6L3E
https://ift.tt/PVX09YR
https://ift.tt/qQxePGK
from Health and Science https://ift.tt/DCA6L3E
https://ift.tt/PVX09YR
https://ift.tt/qQxePGK
Wednesday, 8 November 2023
Amazon adds a new reason to get and keep Prime: member discounts on health-care services
Amazon's (AMZN) new health-care add-on to Prime is the latest example of how the subscription is a valuable deal for its members.
from Health and Science https://ift.tt/qDXRWbi
https://ift.tt/oynzEWM
https://ift.tt/70eFng6
from Health and Science https://ift.tt/qDXRWbi
https://ift.tt/oynzEWM
https://ift.tt/70eFng6
FDA approves Eli Lilly's tirzepatide for weight loss, paving way for wider use of blockbuster drug
The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry.
from Health and Science https://ift.tt/AS3KWL7
https://ift.tt/oynzEWM
https://ift.tt/70eFng6
from Health and Science https://ift.tt/AS3KWL7
https://ift.tt/oynzEWM
https://ift.tt/70eFng6
Pharmacy walkout organizers help launch national push to unionize pharmacists, technicians
The Pharmacy Guild aims to help staff unionize to address what employees have called unsafe working conditions, including at Walgreens and CVS.
from Health and Science https://ift.tt/7Z2gQkA
https://ift.tt/oynzEWM
https://ift.tt/70eFng6
from Health and Science https://ift.tt/7Z2gQkA
https://ift.tt/oynzEWM
https://ift.tt/70eFng6
Health AI startup Cercle debuts with backing from Sheryl Sandberg
A new health technology startup called Cercle is using AI to advance women's fertility care.
from Health and Science https://ift.tt/Rsl6KyM
https://ift.tt/oynzEWM
https://ift.tt/70eFng6
from Health and Science https://ift.tt/Rsl6KyM
https://ift.tt/oynzEWM
https://ift.tt/70eFng6
Tuesday, 7 November 2023
Planet Fitness shares surge as company raises revenue outlook
Planet Fitness now expects its revenue for the year to grow 14%, up from a previous estimate of 12%.
from Health and Science https://ift.tt/OJ025Kz
https://ift.tt/5KMWx0t
https://ift.tt/PJ4pvXj
from Health and Science https://ift.tt/OJ025Kz
https://ift.tt/5KMWx0t
https://ift.tt/PJ4pvXj
Monday, 6 November 2023
Wall Street is asking how weight-loss drugs will affect consumer giants — but it may be too early to tell
Delta, Pepsi, Philip Morris International and Darden Restaurants just some names facing questions about how weight-loss drugs could affect their bottom line.
from Health and Science https://ift.tt/HYj7hqv
https://ift.tt/5KMWx0t
https://ift.tt/PJ4pvXj
from Health and Science https://ift.tt/HYj7hqv
https://ift.tt/5KMWx0t
https://ift.tt/PJ4pvXj
Thursday, 2 November 2023
E-cigarette use declines among high school students, FDA and CDC say
E-cigarette usage among U.S. high school students has fallen as the government pursues aggressive action against companies selling illegal vape products.
from Health and Science https://ift.tt/uxqXUOm
https://ift.tt/jNQzExi
https://ift.tt/sYyU8ej
from Health and Science https://ift.tt/uxqXUOm
https://ift.tt/jNQzExi
https://ift.tt/sYyU8ej
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
The remarks come as U.S. health insurers balk at the extreme cost of Wegovy and other obesity drugs and drop them from their plans.
from Health and Science https://ift.tt/bX9Jgx7
https://ift.tt/jNQzExi
https://ift.tt/sYyU8ej
from Health and Science https://ift.tt/bX9Jgx7
https://ift.tt/jNQzExi
https://ift.tt/sYyU8ej
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
The remarks suggest that Eli Lilly's initial efforts to expand manufacturing capacity for Mounjaro are paying off as demand for the diabetes treatment soars.
from Health and Science https://ift.tt/2eQ0Wf1
https://ift.tt/l748Mxg
https://ift.tt/e3KISlr
from Health and Science https://ift.tt/2eQ0Wf1
https://ift.tt/l748Mxg
https://ift.tt/e3KISlr
Moderna posts quarterly loss as company takes $1.3 billion write-down on unused Covid shots
Moderna's total revenue for the third quarter still topped Wall Street's expectations despite plummeting demand for its Covid-19 shot.
from Health and Science https://ift.tt/4FVkR08
https://ift.tt/l748Mxg
https://ift.tt/e3KISlr
from Health and Science https://ift.tt/4FVkR08
https://ift.tt/l748Mxg
https://ift.tt/e3KISlr
Wednesday, 1 November 2023
The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock
Investors are getting an opportunity to add to their positions in the Medicare Advantage-focused health insurer.
from Health and Science https://ift.tt/bV2hpZd
https://ift.tt/dwOLscX
https://ift.tt/LSXi4qn
from Health and Science https://ift.tt/bV2hpZd
https://ift.tt/dwOLscX
https://ift.tt/LSXi4qn
Doctors have a new way to scrub personal information from internet after spike in harassment
Doximity announced a free new service called DocDefender that can remove a physician's personal phone numbers and addresses from public websites
from Health and Science https://ift.tt/fqvlNWc
https://ift.tt/dwOLscX
https://ift.tt/LSXi4qn
from Health and Science https://ift.tt/fqvlNWc
https://ift.tt/dwOLscX
https://ift.tt/LSXi4qn
CVS results top expectations, lifted by strong health services revenue
The results come on the last day of a nationwide walkout by pharmacy staff from CVS, Walgreens and Rite Aid to protest what they call harsh working conditions.
from Health and Science https://ift.tt/f6px2vi
https://ift.tt/dwOLscX
https://ift.tt/LSXi4qn
from Health and Science https://ift.tt/f6px2vi
https://ift.tt/dwOLscX
https://ift.tt/LSXi4qn